On 25 November Citigroup Inc. (NYSE:C) announced the commencement of offers to purchase for cash certain of its notes of the series set forth in the table below up to an aggregate principal amount with respect to each series of notes ()Maximum Series Tender Cap”). The offer to purchase each series of Notes is referred to as an “Offer” and all such offers are referred to collectively as the “Offers.” Citigroup Inc. (NYSE:C) in last trading activity fell -0.30% to close at $53.97. Company weekly performance is 0.84% while its quarterly performance stands at 4.51%. Citigroup Inc. (NYSE:C) is -2.30% away from its 52 week high.
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) CEO Harvey J. M. D. Berger acquired 25,000 shares of Ariad Pharmaceuticals stock in a transaction that occurred on Thursday, November 20th. The stock was purchased at an average price of $6.15 per share, with a total value of $153,750.00. Following the completion of the acquisition, the chief executive officer now directly owns 1,163,564 shares in the company, valued at approximately $7,155,919. On last trading day Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) fell -2.47% to close at $7.11. Its volatility for the week is 5.44% while volatility for the month is 5.14%. ARIA’s sales growth for past 5 years was 45.10% and its EPS growth for past 5 years was -7.90%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) monthly performance is 21.12%.
On 10 November Akebia Therapeutics, Inc. (NASDAQ:AKBA) announced financial results for the third quarter ended September 30, 2014. Akebia reported a net loss and a net loss applicable to common stockholders of $9.3 million, or ($0.47) per share, for the third quarter of 2014. Net loss applicable to common stockholders for the third quarter of 2013, which includes accretion on preferred stock of $2.7 million, was $6.5 million or ($11.92) per share. On last trading day Akebia Therapeutics, Inc. (NASDAQ:AKBA) fell -7.93% to close at $12.08. Its volatility for the week is 5.97% while volatility for the month is 9.02%. Akebia Therapeutics, Inc. (NASDAQ:AKBA) monthly performance is -7.01%.
On 10 November Horsehead Holding Corp. (NASDAQ:ZINC) reported a consolidated net loss of $7.0 million, or $(0.14) per diluted share, for the third quarter of 2014 compared to a consolidated net loss of $3.5 million, or $(0.08) per diluted share, for the third quarter of 2013. Results for the quarter, adjusted to exclude non-cash adjustments associated with hedges, was a loss of $7.5 million, or $(0.15) per diluted share, compared to a consolidated net loss on the same basis of $2.7 million for the third quarter of 2013, or $(0.06) per diluted share. Horsehead Holding Corp. (NASDAQ:ZINC) has 0.68% insider ownership while its institutional ownership stands at 96.60%. In last trading activity company’s stock closed at $15.62.
Sandridge Mississippian Trust I (NYSE:SDT) issued its quarterly earnings data on Tuesday. The company reported $0.36 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.36. On Friday shares of SandRidge Mississippian Trust I (NYSE:SDT) closed at $3.81. Company’s EPS growth for next 5 years is recorded as 10.00%.